|
Pronunciation |
|
(eye
SOKS syoo
preen) |
|
|
U.S. Brand
Names |
|
Vasodilan® |
|
|
Generic
Available |
|
Yes |
|
|
Synonyms |
|
Isoxsuprine Hydrochloride |
|
|
Pharmacological Index |
|
Vasodilator |
|
|
Use |
|
Treatment of peripheral vascular diseases, such as arteriosclerosis
obliterans and Raynaud's disease |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Presence of arterial bleeding; do not administer immediately
postpartum |
|
|
Adverse
Reactions |
|
1% to 10%: Gastrointestinal: Nausea, vomiting |
|
|
Drug
Interactions |
|
May enhance effects of other vasodilators/hypotensive agents; use with
caution in elderly |
|
|
Mechanism of
Action |
|
In studies on normal human subjects, isoxsuprine increases muscle blood flow,
but skin blood flow is usually unaffected. Rather than increasing muscle blood
flow by beta-receptor stimulation, isoxsuprine probably has a direct action on
vascular smooth muscle. The generally accepted mechanism of action of
isoxsuprine on the uterus is beta-adrenergic stimulation. Isoxsuprine was shown
to inhibit prostaglandin synthetase at high serum concentrations, with low
concentrations there was an increase in the P-G synthesis. |
|
|
Pharmacodynamics/Kinetics |
|
Absorption: Nearly complete
Serum half-life, serum: 1.25 hours mean
Time to peak serum concentration: Oral, I.M.: Within 1 hour
|
|
|
Usual Dosage |
|
Adults: 10-20 mg 3-4 times/day; start with lower dose in elderly due to
potential hypotension |
|
|
Mental Health: Effects
on Mental Status |
|
None reported |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
May cause skin rash; discontinue use if rash occurs; arise slowly from
prolonged sitting or lying position |
|
|
Nursing
Implications |
|
May cause skin rash; discontinue use if rash occurs; arise slowly from
prolonged sitting or lying position |
|
|
Dosage Forms |
|
Tablet, as hydrochloride: 10 mg, 20 mg |
|
|
References |
|
Erwin WG, "Senile Dementia of the Alzheimer Type," Clin Pharm, 1984,
3:497-504.
Waters C,
"Cognitive Enhancing Agents: Current Status in the Treatment of Alzheimer's Disease,"
Can J Neurol Sci, 1988, 15:249-56.
Yesavage JA, Tinklenberg JR, Hollister LE, et al,
"Vasodilators in Senile Dementias: A Review of the Literature," Arch Gen
Psychiatry, 1979, 36:220-3. |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|